In Demand

Ezra Mehlman Named A Top 40 Under 40 Growth Investor of 2023

Retrieved on: 
Wednesday, January 10, 2024

NEW YORK, Jan. 10, 2024 /PRNewswire/ -- Health Enterprise Partners (HEP) is pleased to announce that Ezra Mehlman was recognized as a Top 40 under 40 Growth Investor by Growth Cap.

Key Points: 
  • NEW YORK, Jan. 10, 2024 /PRNewswire/ -- Health Enterprise Partners (HEP) is pleased to announce that Ezra Mehlman was recognized as a Top 40 under 40 Growth Investor by Growth Cap.
  • Ezra was previously recognized as a Top 25 Healthcare Investor by the same organization in 2021 and 2022.
  • 2023 represents GrowthCap's tenth year granting these awards and represented the most competitive contest since inception.
  • Quite frankly, without Ezra and HEP as our key investor and residing on our board, we simply would not have achieved the success that we did.

Ezra Mehlman Named As A Top Healthcare Investor of 2022 by GrowthCap

Retrieved on: 
Wednesday, April 27, 2022

NEW YORK, April 27, 2022 /PRNewswire/ -- Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce that Ezra Mehlman has been recognized as a Top 25 Healthcare Investor for the second year in a row by GrowthCap.

Key Points: 
  • NEW YORK, April 27, 2022 /PRNewswire/ -- Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce that Ezra Mehlman has been recognized as a Top 25 Healthcare Investor for the second year in a row by GrowthCap.
  • The 2022 awardees represent a diverse set of individuals with backgrounds in medicine, science, and technology in addition to finance and investing.
  • Ezra is currently on the board of directors of Wildflower Health, Kno2, and Jvion.
  • After leaving the Advisory Board Company, Ezra served as a Senior Consultant in the healthcare practice of Booz Allen Hamilton focusing on engagements in the provider space.